Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ImmuNe ParameTERs to Predict Immunotherapy REsponse and Toxicity (INTERPRET)

NCT06900296 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT06900296
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06900296 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ImmuNe ParameTERs to Predict Immunotherapy REsponse and Toxicity (INTERPRET)
Lead sponsor
Indiana University
Phase
Observational
Overall status
Not yet recruiting
Start date
January 31, 2028
Completion date
April 30, 2029
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer